Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.56 |
| ▸ | CA2 | P00918 | 6/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 2/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7252868 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL1114761 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL741780 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL744300 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL11719482 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL11381720 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL94158 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL11411801 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL743460 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL31126199 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119192442-A | Material for hydrophilic modification of polytetrafluoroethylene microporous membrane and preparation method thereof | 浙江东大环境工程有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-118976383-A | Polytetrafluoroethylene microporous membrane, hydrophilic modification method thereof and water treatment device | 浙江东大环境工程有限公司 | 2024-11-19 | — | — | CN | claimed |
| US-20250332112-A1 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2025-10-30 | — | — | US | disclosed |
| EP-4574172-A2 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2025-06-25 | — | — | EP | disclosed |
| EP-4466250-B1 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2025-03-26 | — | — | EP | disclosed |
| CN-119192442-A | Material for hydrophilic modification of polytetrafluoroethylene microporous membrane and preparation method thereof | 浙江东大环境工程有限公司 | 2024-12-27 | — | — | CN | disclosed |
| EP-4466250-A1 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2024-11-27 | — | — | EP | disclosed |
| CN-118976383-A | Polytetrafluoroethylene microporous membrane, hydrophilic modification method thereof and water treatment device | 浙江东大环境工程有限公司 | 2024-11-19 | — | — | CN | disclosed |
| CN-118922401-A | Ionizable cationic lipids for lipid nanoparticles | 盖纳万科学有限公司 | 2024-11-08 | — | — | CN | disclosed |
| WO-2023144798-A1 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2023-08-03 | — | — | WO | disclosed |
| CN-105228987-B | Method for preparing pyridazine compound | 住友化学株式会社 | 2017-11-10 | — | — | CN | disclosed |
| US-9732042-B2 | Method for producing pyridazine compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-08-15 | — | — | US | disclosed |
| EP-3004065-A1 | METHOD FOR PRODUCING PYRIDAZINE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2016-04-13 | — | — | EP | disclosed |
| US-20160090363-A1 | METHOD FOR PRODUCING PYRIDAZINE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-03-31 | — | — | US | disclosed |
| CN-105228987-A | For the preparation of the method for pyridazine compound | SUMITOMO CHEMICAL CO | 2016-01-06 | — | — | CN | disclosed |
| EP-0287265-B1 | SILVER HALIDE COLOR PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL | KONICA CORPORATION (JP) | 1991-10-16 | — | — | EP | disclosed |
| US-4916051-A | CYAN COUPLER HAVING HYDROGEN-BONDABLE GROUP | KONICA CORPORATION (JP) | 1990-04-10 | — | — | US | disclosed |
| EP-0287265-A1 | Silver halide color photographic light-sensitive material | KONICA CORPORATION (JP) | 1988-10-19 | — | — | EP | disclosed |
| EP-0027906-B1 | PROCESS FOR PREPARING SULPHON AMIDES | BAYER AG (DE) | 1983-05-25 | — | — | EP | disclosed |
| EP-0027906-A1 | Process for preparing sulphon amides | BAYER AG (DE) | 1981-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160090363-A1 | METHOD FOR PRODUCING PYRIDAZINE COMPOUND | PLP2, PNPO, CBR3 | FAAH 2066/4885CA2 2397/4885TSHR 1636/4885 |
| US-20250332112-A1 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | CETP, NPC1L1, ABCB4 | FAAH 1085/4885CA2 904/4885TSHR 2640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.